Background-We examined the effect of NO on the proliferation and cell cycle regulation of human aortic vascular smooth muscle cells (VSMCs). Methods and Results-The NO donor diethylenetriamineNONOate (10 Ϫ5 to 10 Ϫ3 mol/L) inhibited proliferation in response to 10% fetal calf serum (FCS) and 100 ng/mL platelet-derived growth factor-BB in a concentration-dependent manner. This effect was not observed with disintegrated diethylenetriamineNONOate or with the parent compound, diethylenetriamine. Adenoviral transfection of endothelial NO synthase (NOS) inhibited proliferation in response to FCS, which was prevented with N G -nitro-L-arginine methyl ester. NOS overexpression did not inhibit proliferation in response to platelet-derived growth factor, although the transfection efficiency and protein expression were similar to those of FCS-stimulated cells. Nitrate release was selectively enhanced from FCS-treated cells, indicating that NOS was activated by FCS only. NO caused G 1 cell cycle arrest. Cytotoxicity was determined with trypan blue exclusion, and apoptosis was assessed with DNA fragmentation. Cyclin-dependent kinase 2 expression level, threonine phosphorylation, and kinase activity were inhibited. Cyclin A expression was blunted, whereas cyclin E remained unchanged. p21 expression was induced, and p27 remained unaltered. The effect on cyclin A and p21 started within 6 hours and preceded the changes in cell cycle distribution. Proliferation in response to 10% FCS was barely inhibited with 8-bromo-cGMP (10 Ϫ3 mol/L) but was blunted with both forskolin and 8-bromo-cAMP. Proliferation in response to 2% FCS was inhibited with 8-bromo-cGMP, but it did not mimic the cell cycle effects of NO. Conclusions-NO inhibits VSMC proliferation by specifically changing the expression and activity of cell cycle regulatory proteins, which may occur independent of cGMP. Adenoviral overexpression of endothelial NOS represents a cytostatic strategy for gene therapy of vascular disease. Key Words: endothelium-derived factors Ⅲ nitric oxide Ⅲ nitric oxide synthase Ⅲ platelet-derived factors Ⅲ gene therapy N itric oxide (NO) inhibits platelet aggregation, induces vascular relaxation, and is involved in regulation of the proliferation of vascular smooth muscle cells (VSMCs). 1 Indeed, NO donors inhibit VSMC proliferation, 2 and the overexpression of NO synthase (NOS) in the rat carotid artery reduces neointima formation after balloon dilatation. [3] [4] [5] Cell cycle progression is mediated by cyclin-dependent kinases (cdk). 6 Progression in G 1 phase and entry into S phase are related to the activity of cdk2 in complex with cyclin E and later with cyclin A. 7 Cyclin E expression increases during G 1 and peaks at G 1 -to-S transition; it enters into complexes with cdk2 throughout this time period. 8 Cyclin A expression late in G 1 is important for G 1 -to-S transition, because the inhibition of cyclin A kinase prevents S phase entry. 9 The cdk activity is also affected by cyclin-dependent kinase inhibitors (cki). 10 Both p21 and p27 are cki that interfere with cyclin E and cyclin A kinase activity. p21 is present in cdk complexes of proliferating cells during all phases of the cycle; the conversion of active into inactive complexes is achieved through alteration of the ratio of p21 to cdk. 11 p27 levels are high in growth factor-deprived cells and decline in response to growth factor stimulation; mitogens are the main factor regulating the p27 level. 12 Consistent with these observations in cultured cells, the vascular p27 level in vivo is inversely related to the degree of proliferation after balloon dilatation and thus permits proliferation in the presence of mitogens, whereas p21 is induced during the phase of declining proliferation and contributes to rendering the vessel quiescent. 13 As NO inhibits the proliferation of VSMCs, changes in cell cycle regulation should occur under these conditions unless Received April 16, 1999; revision received October 28, 1999; accepted November 15, 1999. From the Cardiovascular Research (F.C.T., H.G., T.F.L.), Physiology Institute, University Zürich-Irchel; Division of Cardiology (F.C.T., T.F.L.), University Hospital, Zürich, Switzerland; Ophthalmology University Hospital (P.M., C.C.), Basel, Switzerland; and Division of Cardiology (E.G.N.) there was a cytotoxic or an apoptotic effect. The regulation of vascular tone by NO is related to the activation of soluble guanylate cyclase; however, the role of cGMP in the regulation of proliferation remains controversial. 14, 15 In the present study, we examined the effect of an NO donor and NOS transfection on the proliferation of VSMCs and analyzed the cell cycle regulation in the presence of NO and 8-bromo-cGMP.
N itric oxide (NO) inhibits platelet aggregation, induces vascular relaxation, and is involved in regulation of the proliferation of vascular smooth muscle cells (VSMCs). 1 Indeed, NO donors inhibit VSMC proliferation, 2 and the overexpression of NO synthase (NOS) in the rat carotid artery reduces neointima formation after balloon dilatation. [3] [4] [5] Cell cycle progression is mediated by cyclin-dependent kinases (cdk). 6 Progression in G 1 phase and entry into S phase are related to the activity of cdk2 in complex with cyclin E and later with cyclin A. 7 Cyclin E expression increases during G 1 and peaks at G 1 -to-S transition; it enters into complexes with cdk2 throughout this time period. 8 Cyclin A expression late in G 1 is important for G 1 -to-S transition, because the inhibition of cyclin A kinase prevents S phase entry. 9 The cdk activity is also affected by cyclin-dependent kinase inhibitors (cki). 10 Both p21 and p27 are cki that interfere with cyclin E and cyclin A kinase activity. p21 is present in cdk complexes of proliferating cells during all phases of the cycle; the conversion of active into inactive complexes is achieved through alteration of the ratio of p21 to cdk. 11 p27 levels are high in growth factor-deprived cells and decline in response to growth factor stimulation; mitogens are the main factor regulating the p27 level. 12 Consistent with these observations in cultured cells, the vascular p27 level in vivo is inversely related to the degree of proliferation after balloon dilatation and thus permits proliferation in the presence of mitogens, whereas p21 is induced during the phase of declining proliferation and contributes to rendering the vessel quiescent. 13 As NO inhibits the proliferation of VSMCs, changes in cell cycle regulation should occur under these conditions unless there was a cytotoxic or an apoptotic effect. The regulation of vascular tone by NO is related to the activation of soluble guanylate cyclase; however, the role of cGMP in the regulation of proliferation remains controversial. 14, 15 In the present study, we examined the effect of an NO donor and NOS transfection on the proliferation of VSMCs and analyzed the cell cycle regulation in the presence of NO and 8-bromo-cGMP.
Methods

Recombinant Adenovirus
An adenoviral vector for the expression of human placental alkaline phosphatase (hpAP; AdhpAP) and a control virus without the transgene (Ad⌬E1) were prepared as described previously. 16 A similar virus for the expression of endothelial NOS (eNOS; AdeNOS) and the respective control virus were provided by Dr Stefan Janssens (Leuven, Belgium). These viruses were derived from Ad5 dL309 and thus are slightly different from Ad5 sub360. 17 However, a comparison of the effects of both control viruses on VSMC proliferation did not show any difference (nϭ5; data not shown). Therefore, for the sake of clarity, both control viruses are called Ad⌬E1. The titer of purified viruses was determined with plaque assay on 293 cells with the use of an adsorption time of 24 hours and with plaques counted on day 12 after infection. 18 Viral titers ranged from 2ϫ10 10 to 2ϫ10 11 pfu/mL for all preparations. The titer of wild-type virus in the purified preparations was determined with plaque assay on A549 cells under the same conditions and was Ͻ1 in 10 9 pfu/mL for all preparations.
Cell Culture and Cell Transfection
Human aortic VSMCs were obtained from Clonetics and maintained in DMEM (GIBCO) containing 10% fetal calf serum (FCS; GIBCO). VSMCs were used between passages 2 and 10. The 293 and A549 cells were obtained from American Type Culture Collection and were cultured as recommended. The transfection efficiency of VSMC was analyzed with the use of AdhpAP and was determined 24 hours after infection as described previously. 19 An MOI (multiplicity of infection) of 1000 pfu/cell was used for all experiments, because this MOI resulted in the transfection of 99% of VSMCs under our experimental conditions (nϭ4; data not shown). VSMCs infected with Ad⌬E1 and noninfected cells served as negative controls for all experiments.
Proliferation and Nitrate Release
VSMCs were seeded at a density of 10 000 Ϫ3 mol/L; Sigma). DETANO was chosen as the NO donor because it has a half-life of 27 hours and releases NO according to first-order kinetics. Moreover, preliminary experiments demonstrated that spermineNONOate, but not DETANO, induced a cytotoxic effect, which was related to the spermine component of the drug (data not shown). The cells were proliferating in a random manner in response to DMEM with 10% FCS when DETANO treatment or adenoviral transfection was started. The cells were maintained in DMEM containing 10% FCS, media were changed every day, and fresh DETANO was added after every medium change. Cell number was determined every other day for up to 6 days with the use of an hematocytometer. To examine nitrate release, VSMCs were kept in medium with either 10% FCS or 100 ng/mL platelet-derived growth factor-BB (PDGF-BB) for 48 hours after transfection. Nitrate release was assessed with the Griess reaction as described previously. 20 Nitrate concentration was indicated in mol/L and related to the cell number.
Cell Cycle Distribution, Toxicity, and Apoptosis
VSMCs were seeded at a density of 250 000 cells per 150-mm dish and cultured for 24 hours before treatment with DETANO. The cells were exposed to DETANO for 48 hours and were Ϸ60% confluent at the time of analysis. The cells were harvested and analyzed for DNA content with the use of flow cytometry (FACScan cytometer, CellQuest software; Becton Dickinson) as described previously. 21 For the examination of cytotoxicity, VSMCs were gently trypsinized and evaluated for trypan blue exclusion. To assess apoptosis, the percentage of propidium iodide-stained cells with fragmented DNA was evaluated with the use of flow cytometry.
Western Blot Analysis and H1 Kinase Assay
Western blot analysis was performed on whole-cell lysates as described previously. 22 Sixty micrograms of protein was loaded per lane, resolved with SDS-PAGE under reducing conditions, blotted onto PVDF membranes, and analyzed with the use of chemiluminescence (Amersham). Equal loading of proteins was controlled for through staining with Ponceau S and in selected experiments with blotting for ␣-tubulin as well. To determine cdk2 kinase activity, immunoprecipitations were performed as described previously, the kinase reaction was performed for 30 minutes at 37°C in the presence of 10 Ci of [␥-
32 P]ATP (Amersham) with 1 g Histone H1 (Boehringer) as substrate, and labeled proteins were resolved on SDS-15% polyacrylamide gels, followed by autoradiography. 22 
Statistical Analysis
Results represent the mean value of 5 experiments as indicated in the text. Data are expressed as meanϮSEM, and statistical comparisons were performed with Student's t test for unpaired observations or with ANOVA with Dunnett's t test correction whenever appropriate. A 2-tailed P value of Ͻ0.05 was considered to indicate a statistically significant difference. 
Results
Effect of NO on Proliferation
DETANO inhibited VSMC proliferation in response to 10% FCS ( Figure 1A ) and to 100 ng/mL PDGF-BB ( Figure 1B ) in a concentration-dependent manner. When DETANO was used after having decayed during 4 half-lives, it barely inhibited proliferation; similarly, the parent compound DETA did not affect cell number ( Figure 1C ). DETANO had no toxic effect on VSMCs as assessed with trypan blue (GIBCO) exclusion; after treatment for 2 days, the number of cells that excluded trypan blue was 9.77Ϯ0.38% compared with 9.62Ϯ1.23% under control conditions (nϭ5; data no shown).
Adenoviral transfection of the eNOS cDNA inhibited VSMC proliferation in response to 10% FCS ( Figure 2B , left). This effect was dose dependent and resulted in a cell number of 87 750Ϯ5423 under control conditions, 74 938Ϯ5382 at an MOI of 100, 66 125Ϯ5524 at an MOI of 300, 62 063Ϯ3257 at an MOI of 1000, and 60 188Ϯ2339 at an MOI of 3000 compared with 42 250Ϯ1984 at the beginning of the experiment (nϭ4; data not shown). However, no inhibition was observed when proliferation was induced with 100 ng/mL PDGF-BB ( Figure 2B, right) . Transfection efficiency was identical because 99% of VSMCs stained for hpAP under each condition (nϭ4; data not shown). The expression of eNOS protein also was comparable ( Figure  2A ). In contrast, nitrate release was enhanced in the presence of FCS ( Figure 2C, left) , whereas no such effect was observed in the presence of PDGF (Figure 2C, right) . The inhibition of proliferation after eNOS transfection was prevented with the competitive inhibitor of eNOS, L-NAME (Figure 3 ).
Effect of NO on Cell Cycle Regulation
DETANO induced G 1 phase arrest as demonstrated with flow cytometric analysis ( Figure 4A ). There was only a slightly higher number of cells with hypodiploid DNA (Figure 4A ). The expression of proteins that regulated G 1 progression was determined with Western blot analysis. In the presence of DETANO, cyclin A expression was reduced within 24 hours, whereas cyclin E was not affected. p21 level was transiently enhanced within 12 hours, whereas p27 was not affected. cdk2 expression was reduced within 48 hours; this decline was moderate and protracted, because the protein could still be detected after 48 hours. However, the threonine-phosphorylated, and therefore active, cdk2, represented by the lower band of the cdk2 signal, declined faster than the total cdk2 and was no longer detectable within 48 hours. Consistent with these observations, cdk2 kinase activity was blunted within 12 hours ( Figure 4B ). Similar to the proliferation experiments, neither decayed DETANO nor the parent compound DETA induced any change in the expression of cell cycle proteins (data not shown).
The time course of the changes in both cell cycle distribution and protein expression was assessed every 6 hours over 48 hours to correlate these alterations. The shift in cell cycle distribution toward G 1 started by 12 hours of exposure to DETANO and progressively increased over 48 hours ( Figure  5 ). The changes in expression of cyclin A and p21 started by 6 hours and progressively increased over 48 hours, indicating that these changes are primary events and responsible for the G 1 arrest ( Figure 5 ). The expression of both total cdk2 and threonine-phosphorylated cdk2 started to decline within 12 hours only, suggesting that the changes in cdk2 level may occur secondary to the G 1 arrest ( Figure 5 ).
Effect of cGMP-or cAMP-Activating Substances
8-Bromo-cGMP (10
Ϫ3 mol/L) barely affected VSMC proliferation in response to 10% FCS, whereas DETANO completely prevented proliferation at this concentration (Figure 6 , left). In contrast, both 8-bromo-cAMP and forskolin inhibited VSMC proliferation to a similar extent (Table) . 8-BromocGMP (10 Ϫ3 mol/L) inhibited proliferation in response to 2% FCS; the degree of inhibition under these conditions was comparable to that with 10 Ϫ4 mol/L DETANO ( Figure 6 , right). In the presence of both 10% and 2% FCS, the expression of cell cycle regulatory proteins was not affected by 10
Ϫ3 mol/L 8-bromo-cGMP, whereas 10 Ϫ3 and 10 Ϫ4 mol/L DETANO, respectively, altered expression in its typical manner ( Figure 7) .
Discussion
In the present study, the NO donor DETANO inhibited VSMC proliferation in a concentration-dependent manner. .86% of cells were in G 0 /G1 phase, 5.4Ϯ0.51% were in S phase, and 12.8Ϯ0.49% were in G 2 /M phase. Under control conditions, sub-G 1 peak was slightly lower (1.60Ϯ0.29%) compared with that with DETANO treatment (7.80Ϯ1.36%). B, Effect of DETANO on expression of cell cycle regulatory proteins in VSMCs. Cyclin A started to decline within 12 hours of treatment with DETANO (10 Ϫ3 mol/L) and was no longer detectable within 24 hours. In contrast, cyclin E was not affected. p21 was transiently induced within 12 hours of treatment with DETANO. In contrast, p27 was not affected. cdk2 started to decline within 12 hours of treatment with DETANO. This decline was moderate and protracted; protein could still be detected after 48 hours of treatment with DETANO. However, threonine-phosphorylated, and therefore active, cdk2, represented by lower band of cdk2 signal, declined faster and was no longer detectable within 48 hours. As a result of all of these changes, cdk2 kinase activity was blunted within 12 hours of treatment with DETANO.
Consistent with a specific effect, neither decayed DETANO nor the parent substance DETA affected cell number; furthermore, transfection of endothelial NOS inhibited proliferation as well. The effect of NO on proliferation was related to G 1 arrest mediated by complete inhibition of cdk2 kinase activity due to a lower level of both cdk2 and cyclin A as well as by a higher level of p21 protein. 8-Bromo-cGMP was a very weak inhibitor of proliferation and did not induce any of the changes in the expression of cell cycle regulatory proteins observed with NO.
The normal proliferation rates in the presence of a competitive inhibitor of NOS, L-NAME, confirmed that the inhibition of proliferation after NOS transfection was mediated by NO. Although both transfection efficiency and protein expression were similar, this inhibition was observed only when proliferation was stimulated by FCS, not by PDGF-BB. Accordingly, nitrate release was only enhanced in the presence of FCS. Therefore, FCS appears to activate the recombinant enzyme, whereas this is not the case for PDGF. This interpretation is consistent with the observation that PDGF does not induce the release of NO from the endothelium, whereas many serum-derived products do. 23 The cytostatic effect of NO was related to specific alterations in cell cycle regulation during G 1 phase and is consistent with observations from other studies. 24 -27 Indeed, cdk2 kinase activity was blunted; this was in part due to a lower level of both total and threonine-phosphorylated cdk2. 28 Because the decrease in cdk2 and the onset of G 1 arrest occurred simultaneously, it is likely that the lower cdk2 level is a secondary event; indeed, cdk2 expression is maximal in S phase. 28 Independent of its cellular level, cdk2 kinase activity is inhibited by cki. The level of p21 was transiently enhanced by NO. Because the overexpression of p21 induces G 1 arrest in VSMCs, this elevated level is consistent with the antiproliferative effect of the nitrate. 21 The importance of p21 is underscored by the observation that the increase in p21 preceded the onset of G 1 arrest. In addition, the level of cyclin A was reduced in the presence of the nitrate. Because cdk2 exhibits kinase activity only when in a hours of exposure to DETANO, cell cycle distribution started to shift toward G 1 phase and progressively increased over 48 hours. Expression of cyclin A was inhibited and p21 was induced; these changes were first observed within 6 hours of exposure to DETANO. Expression of cdk2 was moderately reduced so that it could still be detected after 48 hours. However, the threonine-phosphorylated, and therefore active, cdk2, represented by the bottom band of cdk2 signal, declined faster and was no longer detectable within 48 hours. Expression of both total and threonine-phosphorylated cdk2 started to decrease within 12 hours of exposure to DETANO. Expression of both cyclin E and p27 remained unaltered during a 48-hour observation period; expression of ␣-tubulin as a control for equal protein loading remained unaltered as well. 
Tanner et al Nitric Oxide and Cell Cycle Regulation
complex with a cyclin, the low level of cyclin A impaired cdk2 kinase activity as well. Similar to p21, the decrease in cyclin A preceded the onset of G 1 arrest. Thus, it is conceivable that NO would induce G 1 arrest in part of the cell population due to the higher level of p21; in addition, in cells that escape this block, NO would arrest proliferation in late G 1 shortly before G 1 -to-S transition due to the lower level of cyclin A. The probably secondary decrease in both total and threonine-phosphorylated cdk2 would enhance the inhibitory effect on G 1 progression. These observations support the concept that specific stimuli lead to distinct changes in G 1 regulation. Indeed, some antiproliferative stimuli act on p21, 29 others act on p27, 30 and some act on cyclins. 31 The pattern of alteration of cell cycle regulatory proteins in the presence of NO is unique and probably cell type specific. 32 8-Bromo-cGMP was a much weaker inhibitor of proliferation than DETANO. However, the inhibitory effects of 8-bromo-cAMP and forskolin were comparable, indicating that bromide derivates of cyclic nucleotides can enter VSMCs in an effective manner. Consistent with the weak effect on proliferation, 8-bromo-cGMP did not affect the expression of any cell cycle regulatory protein that we examined. This was even the case when proliferation was stimulated with 2% FCS and the effect of 10 Ϫ3 mol/L 8-bromo-cGMP on cell number was comparable to that of 10 Ϫ4 mol/L DETANO. Thus, the effect of NO on cell cycle proteins does not seem to be mediated by cGMP. Because the expression pattern of these proteins after treatment with 8-bromo-cAMP is not compatible with that of NO, the effect of the nitrate also is not mediated by cAMP, although this was suggested in a previous study. 15 The effect of NO may be mediated by other signal transduction pathways or be related to protein nitrosylation. Moreover, the effect of NO on p21, cdk2, and cyclin A may not be mediated by the same mechanism but rather may be regulated in an individual manner.
In summary, NO inhibits VSMC proliferation by inducing G 1 phase arrest due to specific alterations in cell cycle regulation. The signal transduction processes that underlie this effect remain unknown, although neither cGMP nor cAMP seems to be involved. The cytostatic effect of NO suggests that the inhibition of neointima formation after balloon dilatation in the rat carotid artery is mediated not only by a reduced thrombus formation, leading to lower local concentrations of platelet-derived mitogens, but also by diminished VSMC proliferation due to a direct effect of NO on cell cycle progression. [3] [4] [5] Therefore, other than cki such as p21 21 or p27 33 and the constitutively active retinoblastoma protein, 34 the transfection of NOS represents a cytostatic gene transfer strategy and may have therapeutic potential for local treatment of vascular disease. mol/L, when proliferation was stimulated with 10% FCS, and at 10 Ϫ4 mol/L, when it was stimulated with 2% FCS. Cyclin A declined to an undetectable level, whereas cyclin E was not affected. p21 was transiently induced, whereas p27 was not affected. cdk2 declined to a lower level. In contrast, 10
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Ϫ3 mol/L 8-bromo-cGMP did not affect expression of any cell cycle regulatory protein with either 10% or 2% FCS.
